Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

IDRA News and Commentary

Caps

How do you think IDRA will perform against the market?

Add Stock to CAPS Watchlist

All Players

143 Outperform
17 Underperform
 

All-Star Players

17 Outperform
4 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top IDRA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted June 17, 2016

Idera's been a confusing stock for me for many years. I started out long in 2010 when the stock seemed to have gotten cheap, only to walk into a buzzsaw of pipeline failures that drove the share price into the pennies. Once I'd given up on the… More

ScreenerStizBear (42.03)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

IDRA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about IDRA.

Recs

1
Member Avatar zzlangerhans (99.83) Submitted: 6/17/2016 9:51:49 AM : Outperform Start Price: $1.50 IDRA Score: +19.60

Idera's been a confusing stock for me for many years. I started out long in 2010 when the stock seemed to have gotten cheap, only to walk into a buzzsaw of pipeline failures that drove the share price into the pennies. Once I'd given up on the company, Baker Bros showed up in 2013 and the stock rose 1000% in a year. Things have been pretty choppy for Idera since then and the pipeline bears little resemblance to what is was in 2013. IMO-8400 keeps migrating from indication to indication and management is piggybacking onto the immunooncology trend with IMO-2125. The bottom line is that after a lot of dilution and money spent, Idera is still laboring in early stage trials and hasn't proven anything. Baker Bros has held steady at 7M shares since buying into a large secondary last year. It's hard for me to get excited about Idera but it's also hard to see this stock slipping back into the pennies with the Bakers on board until their lead compounds have clearly failed a la Xoma.

Recs

0
Member Avatar sk2129 (33.34) Submitted: 11/30/2015 4:39:12 PM : Outperform Start Price: $2.73 IDRA Score: -52.59

baker bros.

Recs

0
Member Avatar bronztan (< 20) Submitted: 9/6/2015 10:35:07 PM : Outperform Start Price: $2.89 IDRA Score: -57.55

Great Stock

Leaderboard

Find the members with the highest scoring picks in IDRA.

Score Leader

qubit15

qubit15 (< 20) Score: +293.06

The Score Leader is the player with the highest score across all their picks in IDRA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
qubit15 < 20 1/21/2009 Underperform NS $7.45 -71.28% +221.79% +293.06 0 Comment
Reboshua 28.16 4/22/2009 Underperform NS $5.96 -64.09% +208.99% +273.08 0 Comment
anticitradeshort 29.07 4/20/2009 Underperform NS $6.09 -64.86% +204.59% +269.45 0 Comment
schwah8 98.48 10/13/2008 Underperform NS $10.65 -79.91% +180.03% +259.93 0 Comment
ScreenerStizBear 42.03 6/26/2008 Underperform NS $14.63 -85.37% +106.23% +191.60 1 Comment
mbeleza < 20 11/14/2007 Underperform 1Y $12.15 -82.39% +81.04% +163.43 1 Comment
eXigy 41.66 9/5/2007 Underperform 1Y $8.80 -75.68% +84.03% +159.72 1 Comment
cowmarx 50.66 8/22/2007 Underperform NS $7.40 -71.08% +85.82% +156.90 0 Comment
TheWINingest < 20 6/4/2007 Underperform 5Y $8.05 -73.42% +77.55% +150.97 0 Comment
MRTShorts 98.52 10/8/2007 Underperform NS $9.28 -76.94% +73.86% +150.80 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRodmanRen < 20 3/24/2010 Outperform NS $5.50 -61.09% +120.45% -181.54 0 Comment
TrackNobleFinanc 29.36 11/21/2008 Outperform NS $5.98 -64.21% +247.08% -311.30 0 Comment
TrackSusquehanna 91.78 5/2/2008 Underperform NS $14.20 -28.73% -38.31% -9.58 10/27/2008 @ $10.12 0 Comment
TrackMDB < 20 5/22/2007 Outperform NS $8.74 -77.00% -9.63% -67.38 4/17/2012 @ $2.01 0 Comment
TrackJanney 82.94 4/18/2007 Outperform NS $8.98 +64.03% -4.22% +68.25 5/7/2008 @ $14.73 0 Comment
trackmerriman 74.29 2/7/2007 Outperform NS $9.45 -77.35% +88.60% -165.95 0 Comment

Featured Broker Partners